GRAIL Poaches New CEO From Roche, Genentech Post author:Sam Post published:December 13, 2017 Post category:BioPharma Four months after Jeff Huber stepped down as CEO of GRAIL, the company has tapped his replacement. Source: BioSpace You Might Also Like Janssen to Terminate Simeprevir License With Medivir, Effective June 2018 December 10, 2017 McKesson Pharma to Pink Slip Some Employees in Wisconsin, Effective March 31 January 19, 2017 Jazz Pharma Bets $175 Million on This Massachusetts Biotech's Antibody-Drug Program August 28, 2017